These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1460710)

  • 1. Iliofemoral versus femorofemoral bypass: the case for an individualized approach.
    Harrington ME; Harrington EB; Haimov M; Schanzer H; Jacobson JH
    J Vasc Surg; 1992 Dec; 16(6):841-52; discussion 852-4. PubMed ID: 1460710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femorofemoral bypass as an alternative to a direct aortic approach in daily practice: appraisal of its current indications and midterm results.
    Rinckenbach S; Guelle N; Lillaz J; Al Sayed M; Ritucci V; Camelot G
    Ann Vasc Surg; 2012 Apr; 26(3):359-64. PubMed ID: 22050878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative evaluation of femorofemoral crossover bypass and iliofemoral bypass for unilateral iliac artery occlusive disease.
    Nazzal MM; Hoballah JJ; Jacobovicz C; Mohan CR; Martinasevic M; Ryan SM; Sharp WJ; Kresowik TF; Corson JD
    Angiology; 1998 Apr; 49(4):259-65. PubMed ID: 9555928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is femorofemoral crossover bypass an option in claudication?
    Capoccia L; Riambau V; da Rocha M
    Ann Vasc Surg; 2010 Aug; 24(6):828-32. PubMed ID: 20638622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease.
    Ricco JB; Probst H;
    J Vasc Surg; 2008 Jan; 47(1):45-53; discussion 53-4. PubMed ID: 17997269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome.
    Criado E; Burnham SJ; Tinsley EA; Johnson G; Keagy BA
    J Vasc Surg; 1993 Sep; 18(3):495-504; discussion 504-5. PubMed ID: 8377244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of unilateral iliac artery disease by femorofemoral bypass grafting.
    Sheiner NM; Ashby D; Zeltzer J
    Can J Surg; 1979 Sep; 22(5):474-6. PubMed ID: 159115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bypass, endarterectomy, extra-anatomic bypass and endovascular surgery in unilateral iliac occlusive disease: a review of 1257 cases.
    Lorenzi G; Domanin M; Costantini A; Rolli A; Agrifoglio G
    Cardiovasc Surg; 1994 Jun; 2(3):370-3. PubMed ID: 8049976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femorofemoral bypass grafts: Factors influencing long-term patency rate and outcome.
    Mingoli A; Sapienza P; Feldhaus RJ; Di Marzo L; Burchi C; Cavallaro A
    Surgery; 2001 Apr; 129(4):451-8. PubMed ID: 11283537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current role for femorofemoral bypass.
    Kalman PG; Hosang M; Johnston KW; Walker PM
    J Vasc Surg; 1987 Jul; 6(1):71-6. PubMed ID: 2955134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iliac angioplasty as a prelude to distal arterial bypass.
    Katz SG; Kohl RD; Yellin A
    J Am Coll Surg; 1994 Nov; 179(5):577-82. PubMed ID: 7952462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Femorofemoral crossover bypass for noninfective complications of aortoiliac surgery.
    François F; Picard E; Nicaud P; Albat B; Thévenet A
    Ann Vasc Surg; 1991 Jan; 5(1):46-9. PubMed ID: 1997075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femorofemoral bypass graft: choice or compromise?
    Sethi GK; Crawford FA; Scott SM; Takaro T
    Am Surg; 1975 Feb; 41(2):61-6. PubMed ID: 123714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of semiclosed endarterectomy of the superficial femoral artery and the outcome of failed reconstructions.
    van der Heijden FH; Eikelboom BC; van Reedt Dortland RW; van der Graaf Y; Steijling JJ; Legemate DA; Theodorides T; van Vroonhoven TJ
    J Vasc Surg; 1993 Aug; 18(2):271-9. PubMed ID: 8350437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dacron and polytetrafluoroethylene aorto-bifemoral grafts].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanović PL; Velimirović LB; Marković DM; Pejkić SL; Pavlović G
    Srp Arh Celok Lek; 1997; 125(3-4):75-83. PubMed ID: 9221522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease.
    Donker JM; Ho GH; Te Slaa A; de Groot HG; van der Waal JC; Veen EJ; van der Laan L
    Vasc Endovascular Surg; 2011 Oct; 45(7):598-603. PubMed ID: 21757494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial.
    Klinkert P; Schepers A; Burger DH; van Bockel JH; Breslau PJ
    J Vasc Surg; 2003 Jan; 37(1):149-55. PubMed ID: 12514593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of donor limb hemodynamics in femorofemoral bypass for claudication.
    Harris JP; Flinn WR; Rudo ND; Bergan JJ; Yao JS
    Surgery; 1981 Oct; 90(4):764-73. PubMed ID: 6456562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial.
    Eiberg JP; Røder O; Stahl-Madsen M; Eldrup N; Qvarfordt P; Laursen A; Greve M; Flörenes T; Nielsen OM; Seidelin C; Vestergaard-Andersen T; Schroeder TV
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):431-8. PubMed ID: 16807001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.